Paper2416628
Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
Steinberg WM and 6 others. Gastroenterology, 1986. Cited by 236 papers, by iCite.
Cite this record
ConductScience Library. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Papers, record 2416628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2416628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Antibodies, Monoclonal | Major topic |
| Antigens, Neoplasm | Major topic |
| Carcinoembryonic Antigen | Major topic |
| Epitopes | Major topic |
| Pancreatic Neoplasms | Major topic |
| Antigens, Tumor-Associated, Carbohydrate | |
| Humans | |
| Radioimmunoassay |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42824914 | ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42824914 | PubMed |
| 42738303 | Serum SAMD9 as a Potential Prognostic Biomarker for Pancreatic Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738303 | PubMed |
| 42587626 | A Clinical Score to Identify Individuals at High Risk of Pancreatic Cancer in the General Population. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42587626 | PubMed |
| 41463153 | CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463153 | PubMed |
| 39849359 | High serum CA19-9 predicts severe cholecystitis in calculous cholecystitis patients. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/39849359 | PubMed |
| 39529638 | Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. | Gastro Hep Adv | 2024 | https://conductscience.org/library/papers/39529638 | PubMed |
| 38493006 | Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy? | Blood Rev | 2024 | https://conductscience.org/library/papers/38493006 | PubMed |
| 37373743 | CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. | J Clin Med | 2023 | https://conductscience.org/library/papers/37373743 | PubMed |
| 35277545 | Clinical features and prognostic impact of asymptomatic pancreatic cancer. | Sci Rep | 2022 | https://conductscience.org/library/papers/35277545 | PubMed |
| 33333055 | Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. | Gastroenterology | 2021 | https://conductscience.org/library/papers/33333055 | PubMed |
| 32089746 | Refining Cancer Management Using Integrated Liquid Biopsy. | Theranostics | 2020 | https://conductscience.org/library/papers/32089746 | PubMed |
| 31221853 | The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. | Science | 2019 | https://conductscience.org/library/papers/31221853 | PubMed |
| 30766566 | comparative study of carbohydrate antigen 19-9 in sickle cell disease subjects and controls in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. | Afr Health Sci | 2018 | https://conductscience.org/library/papers/30766566 | PubMed |
| 29151947 | Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis. | J Cancer | 2017 | https://conductscience.org/library/papers/29151947 | PubMed |
| 28536479 | Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease. | Sci Rep | 2017 | https://conductscience.org/library/papers/28536479 | PubMed |
| 28511463 | Unusually High Serum Levels of CA 19-9 in an Ovarian Tumour: Malignant or Benign? | J Clin Diagn Res | 2017 | https://conductscience.org/library/papers/28511463 | PubMed |
| 28367245 | The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study. | J Cancer | 2017 | https://conductscience.org/library/papers/28367245 | PubMed |
| 27053885 | Clinical significance of CA19-9 in diagnosis of digestive tract tumors. | World J Gastroenterol | 1997 | https://conductscience.org/library/papers/27053885 | PubMed |
| 25580353 | The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection. | J Gastric Cancer | 2014 | https://conductscience.org/library/papers/25580353 | PubMed |
| 25191515 | Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines. | Cytojournal | 2014 | https://conductscience.org/library/papers/25191515 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2416628
GET https://conductscience.org/api/papers/v1/2416628/cited_by?page=2